The Burden of Diabetes (Care)

Now that there is a plethora of clinicaltrial data with clinically meaningfulend points proving that the burden of diabetes can be improved by a variety of interventions, including glycemic, blood pressure, and lipid control; the use of statins, ACE inhibitors, and aspirin; ap-propriately timed laser therapy for dia-betic retinopathy; and screening of feet at high risk for neuropathic ulcers, it is now time to evaluate just how well we do with our current level of care. Over the past few years, there have been a variety of surveys indicating that despite our evidenced-based clinical trial data, diabetes care in the U.S. has been abysmal. Several of these reports have focused on levels of